Birla Institute of Technology, Mesra
   
DR. (MRS.) S.M. VERMA
Professor , Pharmaceutical Sciences and Tech
M. Pharm., Ph.D., FIC, FICS
Contact Address
Residence Address Deptartment of Pharmaceutical Sciences, Birla Institute of Technology, Mesra, Ranchi-835215, Jharkhand, India
Permanent Address Deptartment of Pharmaceutical Sciences, Birla Institute of Technology, Mesra, Ranchi-835215, Jharkhand, India
Phone (Office) 06512275444
Phone Residence 9534047294
Email Id smverma275730@yahoo.com
   Joined Institute on : 16-Aug-1990

  Work Experience
 
Teaching : 28 Years

Research : 28 Years

Individual: 28 Years


  Professional Background
 

 

  Faculty at  University of Kashmir, Srinagar (J&K)

     - Lecturer (Hony.)                      October 1986– February 1987           

Faculty at Academy of Medical Sciences,V.L. College of Pharmacy, Raichur,Karnataka (Under Gulburga University)

     - Lecturer                                    August 1987 – July 1988

      Faculty at Patliputra College of Pharmacy Bailey Road, Patna

    - Assistant Professor                   August 1988–December 1988              

Faculty at B.I.T., Mesra

   - Research Associate                    July 1990   – May 1994

  - Associate Lecturer                        May 1994 – March 1995

   -Assistant Professor/Lecturer        April 1995 – June 2003                      

   -Senior Lecturer                             July 2003 – May 2007

   -Lecturer  (Selection Grade)          June 2007 – February 2009

   -Redesignated as Reader              March 2009 – May 2010

   -Associate Professor                      June 2010 – May 2016

   -Professor                                      June 2016 – Till date


  Research Areas
 

1. Pharmaceutical Chemistry

2. Synthetic Organic Chemisty

3. Natural Product Chemistry

4. Computer Aided Drug Design


  Award and Honours
 

1. Best paper award in National Seminar on Recent trends in Drug Discovery, Bilaspur, 2008.

2. Best paper award in Eastern Regional Conference, Indian Pharmacological Society, Ranchi, 2008. 


   Publications
 

International Journals

1. Poonam Vats, S Manaswita Verma and Tausif Monif Mechanistic Evaluation of Matrix Effect on Three Different Model of Mass Spectrometer by Using a Model Drug Journal of Analytical & Bioanalytical Techniques 2016, 7:3

2. Poonam Vats, S. Manaswita Verma, Tausif Monif . Novel LC–MS/MS method for estimation of niacin with negligible matrix effect and its application to the BE study Journal of Pharmaceutical Investigation May 2017, Volume 47, Issue 3pp 241–248 

3. Pinki Rawat and Saurabh M Verma. Design and synthesis of Chroman derivatives with dual Anti-breast cancer and antiepileptic activities. Drug Design, Development and Therapy, 2016, 10, 2779-2788.[Impact Factor: 2.881] 

4. Pinki Rawat, Saurabh Manaswita Verma. “Synthesis and Pharmacological Evaluation of 6-Hydroxy-2,5,7,8-tetramethyl-N'-(2-oxoindolin-3-ylidene)chroman-2-carbohydrazide Derivatives as Antimicrobial Agents” – Journal of Chemical & Pharmaceutical research, 2016, 8(3), 149-154.

5. Pankaj Partani, S. M. Verma, Tausif Monif. “Development and validation of an LC-MS/MS method for the determination of Simvastatin and its active metabolite, Simvastatin acid, in human plasma and its application to pharmacokinetic study” –Journal of Chromatographic Science, 2016, DOI 10.1093/chromsci/bmw087 (Accepted). [Impact Factor: 1.363]

6. Neeru Singh, Saurabh Manaswita Verma, Sandeep Kumar Singh and Priya Ranjan Prasad Verma. “Evidence from bacterial activities of Lipidic Nanoemulsions against Pseudomonas aeruginosa” – Antonie Van Leeuwenhoek, 2015 107(6), 1555-68. [Impact Factor: 2.2]

7. Poonam Vats, S. Manaswita Verma, Arshad Khuroo and Tausif Monif. “Effects of Sample Processing Techniques and Instrument Model on Matrix Effect in LC-MS/MS for a Model Drug” – Journal of Liquid Chromatography & Related Technologies, 2015, 38(13), 1315-23. [Impact Factor: 0.64]

8. Neeru Singh, Saurabh Manaswita Verma. “Anti-Bacterial Screening and Optimization of Lipids for the Preparation of Nanoemulsions” - Research Journal of Pharmacy & Technology, 2015, 8 (6), 713-718.

9. Vandana Kumari, Saurabh Manaswita Verma. “Synthesis of 8 - azabicyclo [3.2.1] octanes derivatives and its docking study on 2a79, 3g90 and 1ff4” - Indo American Journal of Pharmaceutical Research, 2015, 5 (7),2484-96.

10. Pinki Rawat, Saurabh Manaswita Verma. “Docking Studies of Substituted Chroman Analogs at Estrogen Receptor” - Asian J Pharm Clin Res, 2015, 8 (6), 1-5.

11. Pankaj Partani, Saurabh Manaswita Verma, Tausif Monif. Liquid chromatography tandem mass spectrometry method for the quantitation of mycophenolate mofetil in human plasma: Application to a bioequivalence study and metabolite identification. Journal of Separation Science, 2015, 38(20), 3533-44. [Impact Factor: 2.737]

12. Neeru Singh, Saurabh Manaswita Verma, Sandeep Kumar Singh and Priya Ranjan Prasad Verma. “Consequences of lipidic nanoemulsions on morphology and membrane integrity of Staphylococcus aureus using Transmission Electron Microscopy, Scanning Electron Microscopy and Atomic Force Microscopy” – Material Research Express, 2014, 1 (2), 1-23.

13. Kalyan K. Sethi and Saurabh M. Verma. “A systematic quantitative approach to rational drug design and discovery of novel human carbonic anhydrase IX inhibitors” – Journal of Enzyme Inhibition & Medicinal Chemistry, 2014, 29 (4), 571-581. [Impact Factor: 2.332]

14. Pankaj Partani, S. Manaswita Verma, Sanjay Gurule, Arshad Khuroo and Tausif Monif. “Simultaneous quantitation of atorvastatin and its two active metabolites in human plasma by liquid chromatography/(-) electrospray tandem mass spectrometry” – Journal of Pharmaceutical Analysis, 2014, 4 (1), 26-36. 

15. Brijesh Patel, Saurabh M. Verma and Kalyan K. Sethi. “3D-QSAR and Docking studies of N-hydroxy 1,8-naphthyridine 2-one analogues as Ribonuclease H  Inhibitors” – Letters in Drug Design & Discovery, 2013, 10 (9), 823-835. [Impact Factor: 0.872]

16. Kalyan K. Sethi, Saurabh M. Verma. “Pharmacophore modeling and 3D QSAR studies of novel human carbonic anhydrase IX inhibitors” – Letters in Drug Design & Discovery, 2013, 10(9), 808-816. [Impact Factor: 0.872]

17. Kalyan K. Sethi, Saurabh M. Verma, Muhammet Tanç, Fabrizio Carta, and Claudiu T. Supuran. “Carbonic Anhydrase Inhibitors: Synthesis and Inhibition of the cytosolic mammalian carbonic anhydrase isoforms I, II and VII withbenzene sulfonamides incorporating 4,5,6,7-tetrachlorophthalimide” – Bioorganic & Medicinal Chemistry, 2013, 21(17), 5168–5174. [Impact Factor: 2.793]

18. Kalyan K. Sethi, Daniella Vullo, Saurabh M. Verma, Muhammet Tanç, Fabrizio Carta, and Claudiu T. Supuran. “Carbonic Anhydrase Inhibitors: Synthesis and inhibition of the human carbonic anhydrase isoforms I, II, VII, IX and XII with benzene sulfonamides incorporating 4,5,6,7-tetrabromophthalic anhydride moiety” – Bioorganic & Medicinal Chemistry, 2013, 21, 5973–5982. [Impact Factor: 2.793]

19. Padma C. Behera, S. M. Verma, Posa Mahesh Kumar, Nalin B. Das, Pravat M.Mishra and Sasmita Baliarsingh. “Anti-Inflammatory and Anti-Microbial Activity of Chalcone from Dalbergia Sissoo Roxb. Leaves” – American Journal of Phytomedicine and Clinical Therapeutic, 2013, 1, 186-194.

20. Neeru Singh, Saurabh Manaswita Verma, Sandeep Kumar Singh, Priya Ranjan Prasad Verma and Mohd. Neyaz Ahsan. “Antibacterial activity of cationised and non-cationised placebo lipidic nanoemulsion using transmission electron microscopy” – Journal of Experimental Nanoscience, 2013, 10 (4), 299-309. [Impact Factor: 1.04]

21. Neeru Singh, Saurabh Manaswita Verma, Sandeep Kumar Singh, Priya Ranjan Prasad Verma and Mohd. Neyaz Ahsan. “Antibacterial action of lipidic nanoemulsions using atomic force microscopy and scanning electron microscopy on Escherichia coli” – Journal of Experimental Nanoscience, 2013, 10 (5), 381-391. [Impact Factor: 1.04]

22. Dadheech M, S.M. Verma, Meena R.P. “Design and synthesis of some Benzthiozole analogs as A2A receptor antagonists” – Journal of Pharm Sci Tech. 2012; 4, p. 873- 882. 

23. S.M. Verma, M. Diwan, B. Kumari. “Design, Synthesis and Evaluation of some benzthiazole thiosemicarbazone as Antimicrobial Agents” – International Journal of Drug Design & Discovery, 2012; 3, p. 766-771. 

24. Saurabh M. Verma, Arabinda Saha, Rahul Mishra and Kalyan K. Sethi. “3D-QSAR study of some heterocyclic sulfonamide analogs as hCAII inhibitors” – Letters in Drug Design & Discovery, 2012; 9, p. 581-86. [Impact Factor: 0.872]

25. Kalyan K. Sethi, S.M. Verma, Naru Prasanthi, M. M. Annapurna. “Synthesis, Neurotoxicity and Anticonvulsant Study of Some Benzthiazole Analogs” – Letters in Drug Design & Discovery, 2011; 8, p. 774-777. [Impact Factor: 0.845]

26. Kalyan K. Sethi, Saurav M. Verma, Jayaprakash N. Pichikala1, Padilam Suresh. “Synthesis and Study of Anti Parkinsonism Activity of 8-Azabicyclo [3.2.1] Octane Analogs” - Pharmacology & Pharmacy, 2011; 2, p. 94-99.

27. K.K Sethi, S.M. Verma, P.M. Kumar, R. Mishra, C.T. Supuran. “Carbonic anhydrase I and II inhibition with natural products: Leucas Cephalotus” – Pharmacognosy Communications, 2011; 1(2), p. 40-45. 

28. S.M. Verma, K.B. Suresh and A. Verma. “Antidiabetic activity of leaves of Indigofera Tinctoria Linn. (Fabaceae)” – International Journal of Toxicological and Pharmacological Research, 2010; 1(2), p.2. 

29. S.M. Verma, K.K. Sethi, N. Prasanthi, S.K. Sahoo, R.N. Parhi, P. Suresh, “3D-QSAR study of benzene sulfonamide analogs as carbonic anhydrase II inhibitors” – Bioorganic and Medicinal Chemistry Letters, 2010; 20, p. 3089-3093. [Impact Factor: 2.338]

30. S.M. Verma, A. Sharon, K. Aagarwal and S.P. Ghatol. “Pharmacophore distance mapping and docking study of some Benzimidazole Analog as A2A receptor antagonist” – Int J Pharm Sci Drug Res. 2010; 2, p. 71-77.

31. S.M. Verma and R. Suresh Kumar. “Sedative/hypnotic, anticonvulsant and anti-microbial studies on Calotropis gigantea leaf extracts” – Humdard Medicus, 2010; 53 (3), p 87-89. 

32.  S.M. Verma, B.K. Razdan and D. Sasmal “3D-QSAR study of 8-azabicyclo [3.2.1] octane analogs antagonists cholinergic receptor” – Bioorganic & Medicinal Chemistry Letters, 2009; 19, p. 3108-3112. [Impact Factor: 2.338]

33. S.M. Verma, P. Dewangan, A. Basu and Venkateshan J. “Multidimensional consensus QSAR: A step towards integrating CoMFA, CoMSIA with traditional QSAR methodologies” – Letters in Dug Design and Discovery, 2008; 5, p. 494-502. [Impact Factor: 0.845]

 34. S.M Verma and A. Gunakunru “Quantitative structure activity relationship of riluzole series as anticonvulsants” – Asian Journal of Chemistry- An International Bimonthly Research Journal of Chemistry, 2007; 19(4), p. 2843-2849. 
 
National Journals
 
1. S.M.Verma, L. Khani, A. Gunnakunru and A. Saha. “Synthesis and anticonvulsant activity of hetrocyclic sulphonamides” – J. of Institution of Chemists, 2008, 80 (1), p. 8-13. 

2. S.M.Verma, P.R.P.Verma, and Ashok R. Chandak. “Spectrophotometric analysis of methotrexate and its validation” – J. of Institution of Chemists, 2007, 79(5), p. 159-160.

3. S.M.Verma, P.R.P. Verma, and Ashok R. Chandak. “Spectrophotometric analysis of pentazocine and its validation” – J. of Institution of Chemists, 2007, 79(6), p. 167- 168.

4. S.M.Verma, P.R.P. Verma, and Ashok R. Chandak. “Spectrophotometric analysis of valdecoxib and its validation” – J. of Institution of Chemists, 2007, 79 (6), p. 182-183.

5. S.M.Verma. “SERM- scope and opportunities” – Pharmbit, 2006, p. 39-40.    

6. S.M.Verma, P.R.P. Verma, and H. Verma, “Spectrophotometeric Analysis of tramadol hydrochloride and its validation” – J. of Institution of Chemist, 2005, 77 (1), p.10.

7. S.M.Verma, P.R.P. Verma, H. Verma, and M. Gupta. “Spectrophotometric analysis of meloxicam and its validation” – J. of Institution of Chemist, 2005, 77 (1), p.11.

8. S.M.Verma, P.R.P. Verma, H. Verma, N. Bairwa and A. Sinha. “Development and validation of new spectrophotometric method for analysis of nimesulide” – J. of Institution of Chemist, 2005, 77 (1), p.19.

9. S.M.Verma, Amrisha, J. Prakash, V.K. Shah. “Phyto-pharmacognostical Investigation and Evaluation of Anti-inflammatory and Sedative Activity on leaves of  Erythrina indica Lam.” –Ancient Science of Life, J. of International Institute of Ayurveda, 2005, XXV(2), p. 79-83.

10. S.M.Verma, K. Das and L. Khani. “Synthesis and anti-convulsant evaluation of 5-sulfomoyl-1,3,4- thiadiazolyl-2-thisemicarbazone” – Journal of Institution of Chemist, 2004, 76 (3), p. 89-92. 

11. S.M.Verma, J. Nag. “Nutraceutical and dietry management in cancer therapy” – Pharmbit, 2004, p. 49-50.

12. S.M.Verma, H. Arora and R. Dubey. “Anti-inflammatory and sedative-hypnotic activity of the methanolic extract of the leaves of Mentha arvensis” – Ancient Science of Life, J. of International Institute of Ayurveda, 2003, XXIII (2), p. 95-99.

13. S.M.Verma and K.B. Suresh. “Phyto-chemical investigation of Indigofera tinctoria Linn leaves ” – Ancient Science of Life , J. of International Institute of Ayurveda, 2002, XXI (4), p.235-239.

14. S.M.Verma, R. Prasad and N. Kudada. “Investigation of antiviral properties on extract of Pleurotus sajor caju” – Ancient Science of Life, J. of International Institute of Ayurveda, 2001, XXI (1), p 34-36.

15. S.M.Verma, P. Ramchandran and R.K Verma. “Phyto-chemical characterization and anti-microbial activity of Vitex negundu leaves” – Ancient Science of Life, J. of International Institute of Ayurveda, 2001, XXI (2), p.96-98.

16. S.M.Verma and M.S. Raghvendra. “Oxicams as innovative anti-inflammatory Agents” – Pharmbit, 2000, p. 10-12. 

17. S.M.Verma and R. Jhingran. “French bean – a multifaceted plant” – Pharmbit, 2000, p. 19-20.


Conference Proceedings     

      
1. S.M. Verma and Pinki Rawat. “Docking Studies of Substituted Chroman Amides” – 21st ISCB International Conference at CDRI, Lucknow, 25th-28th Febraury 2015.

2. S.M. Verma, Pinki Rawat and Subhradeep Bahr. “An insight to combat Cancer through Benzopyran” – 2nd Pharm. Tech. IAPST International Conference at Jadavpur University, Kolkata, 17th-19th January 2014.

3. S.M. Verma, Mohit Jaiswal, Hindol Sarkar and Kalyan Sethi.  “An insight into human Carbonic Anhydrase II Inhibitors as Anti-epileptic” – 2nd Pharm. Tech. IAPST International Conference at Jadavpur University, Kolkata, 17th-19th January 2014. 

4. S.M. Verma, Subhradeep Bahr and Pinki Rawat. “Generation of 3D-Model for Human CCR5 Chemokine Receptor through Homology Modeling & Identification of Potent Inhibitors by Molecular Docking Studies” – Recent Advances in Computational Drug Design at IISc Bangalore, 16th-17th September 2013.

5. S.M. Verma, Mohit Jaiswal, Hindol Sarkar and Kalyan Sethi. “A potential study based on 3D-QSAR, docking and pharmacophore modeling of uredio-substituted sulfamates as human Carbonic Anhydrase II inhibitors” – Recent Advances in Computational Drug Design at IISc Bangalore, 16th-17th September 2013.

6. S.M. Verma, N. Padma and Sachin. “Molecular docking studies of some N-Substituted guanidine derivatives as NMDA receptor antagonists” – Recent trends in Pharmaceutical Education, IIT, BHU, 5th March 2011. 

7. S.M. Verma, Khushboo Agarwal, Ashok Sharoan. Santosh P Ghatol. “Pharmacophore Distance Mapping and Docking study of some benzimidazole derivatives as A2A receptor antagonist” – 14th APTI. Jodhpur, 3rd-4th Oct. 2009.

8. S.M. Verma, A. Gunakunnro, A. Saha and R.P. Meena. “Synthesis and anticonvulsant activity of some novel benothiazole sulfonamide analogs” – 14th APTI. Jodhpur, 3rd-4th October, 2009.

9. S.M. Verma, K.B. Suresh and A. Verma. “Antidiabetic activity of leaves of Indigofera Tinctoria Linn. (Fabaceae)” – 14th APTI. Jodhpur, 3rd-4th October, 2009.

10. S.M. Verma, D. Sasmal, B.K. Razdan, Verma Amit. “Molecular modeling and drug design of Tropane analog” – International conference of Indian chemical society, VIT, Vellore, 2nd-6th Dec 2009.

11. S.M. Verma, N. Padma, Amit Verma, Santosh P. Ghatol. “Synthesis and pharmacology of some novel N-substituted guanidine derivatives as NMDA receptor antagonist” – 61st IPC December 2009, Ahmedabad, Gujarat.

12. S.M. Verma, A. Basu, P. Dewangan. “3D QSAR study of N-substituted guanidine derivatives as NMDA  receptor antagonists” – National Seminar on Recent Trends in Drug Discovery,  Bilaspur, 2008.

13. S.M. Verma and N. Singh. “Isolation, identification and optimization of some lipase producing fungi” – Indian Pharmacological Society, RIMS, Ranchi- 19th-20th April 2008.

14. S.M. Verma, A. Basu, P. Diwangan. “QSAR study of guanidine analogs as NMDA receptors antagonists” – Eastern Regional conference, Indian Pharmacological Society, RIMS, Ranchi- 19th-20th April 2008.

15. S.M. Verma, B.K. Razdan and D. Sasmal. “In vivo subject on some tropane analogs” – Indian Pharmacological Society, RIMS, Ranchi- 19th-20th April 2008.

16. S.M. Verma, B.K. Razdan and D. Sasmal. “Computer aided studies on some cholinergic receptors antagonists as potential antiparkinsonian agents” – Indian Pharmacological Society, RIMS, Ranchi- 19th-20th April 2008.

17. S.M. Verma, P. Dewangan, K. Sethi, and N. Padma. “Docking studies of N,N’-Bis Substituted Aryl Guanidine Derivatives as NMDA receptor antagonist” – 13th APTI National Convention, 3rd-4th October, 2008.

18. S.M. Verma, A. Gunakunaru and K. Sethi. “Design, synthesis and Biological Activities of some hCA II inhibitors” – 60th Indian Pharmaceutical Congress N. Delhi, 12th-14th December, 2008.

19. S.M. Verma, A. Basu, P. Dewangan, and N. Padma. “Synthesis and docking studies of N,N’-Bis Substituted Aryl Guanindines Derivatives as NMDA receptor antagonist” – 60th Indian Pharmaceutical Congress N. Delhi, 12th-14th December, 2008.

20. S.M. Verma, k. Jayaram Kumar, C.M. Prasad, P.R.P. Verma, S. Samanta. “Gums and modified gums in conversion of traditional ayurvedic formulation into unit dosage forms” – National seminars on value added products of commercial importance from natural resins and gums, Namkum Ranchi, September 2007.   

21. S.M. Verma, A. Saha, V. Kumar. “Design, synthesis and anticonvulsant evaluation of some aromatic sulphonamides” – 59th Indian Pharmaceutical Congress, Varanasi, Dec, 2007.

22. S.M. Verma, A. Gunnakunru and A. Saha. “Synthesis and study of some benzthiazole analogs” – 58th Indian Pharmaceutical Congress, Mumbai, December, 2006.

23. S.M.Verma, B.K.Razdan, A.Gunnakunaru. “Synthesis of various families of 4-amino antipyrine” – National Seminar, ‘Emerging Trends in Synthetic Aspects of Medicinal Chemistry’ Warangal, 28th-29th October 2005. 

24. S.M. Verma, P.R.P.Verma, AshokRChandak and R.N.Mandal. “Development and validation of new spectrophotometric method for analysis of valdecoxib” – 57th Indian Pharmaceutical Congress, Hydrabad, December, 2005. 

25. S.M.Verma and L. Khani. “Synthesis and Anti-Convulsant evaluation of 5-sulfamoyl 1,3,4 –Thiadiazolyl derivatives” – 8th National Conference on Chemistry and Biology : The path to Drug Discovery, Indian Society of Chemists and Biologists, CDRI, Lucknow, 2004.

26. S.M.Verma, L. Khani, J. Nag and J. Prakash. “Nutraceutical and herbal remedies: emerging trends in Indian Medicinal Plants” – National  Symposium : Emerging Trends in Indian Medicinal Plant, Lucknow, 2003.

27. S.M.Verma R. Jhingran, R. Gupta, S. Kumar and Amrisha. “Premna integrifolia: Phytochemical studies on root extract and its anti-inflammatory action” – 55th Indian Pharmaceutical Congress, Chennai, 2003.

28. S.M.Verma, Md. K.A.M. Diwan and L. Khani. “Anticonvulsant, sedative - hypnotic and antimicrobial activity of some benzimidazole thiosemicarbazones” – 7th National Conference of Indian Society of Chemists and Biologists, CDRI- Lucknow at Agra, 2003.

29. S.M.Verma, M.S. Raghvendra, A.C. Mishra. “Synthesis and anti-inflammatory activity of some analogs of Oxicam” – 53rd Indian Pharmaceutical Congress, New Delhi, 2001.

30. S.M.Verma, Mohamed Divan, M.K.A., M.J. Baskar, P. Harikrishnan. “Pharmacognistical, phytochemical, antimicrobial and larvicidal screening of stem bark of Crataeva religiosa Forst” – 53rd Indian Pharmaceutical Congress, New Delhi, 2001.

31. S.M.Verma, R. Prasad and N. Kudada. “Investigation on Pleurotus sajor caju extract for antiviral activity” – National Seminar on Pharmacy, Education and Research Yesterday, Today and Tomorrow, Birla Institute of Technology, Ranchi, November,1998.

32. S.M.Verma and B. Saha. “Determination of taxol in the leaves of himalayan yew by HPLC”– 49th Indian Pharmaceutical Congress, Trivendrum, 1997.

33. S.M.Verma, B.M. Reddy, A.K. Sharma and B.K. Razdan. “Synthesis of new analogs of 9-methyl-3, 9-diazabicyclo[4.2.1] nonane and 10-methyl-3, 9-diazabicyclo[4.3.1] decane” – 39th Indian Pharmaceutical Congress, Madras 1988.

 

 


  Member of Professional Bodies
 

(a). Life Member:

1. Indian Pharmaceutical Association (IPA)

2. Indian Pharmacy Graduates' Association (IPGA)

3. Indian Society for Technical Education (ISTE)

4. Pharmaceutical Society, B.I.T., Mesra, Ranchi

(b). Registered Pharmacist

1. Pharmacy Council of India

(c). Executive Council Member

1. IPA, Jharkhand Branch


  Current Sponsored Projects
 
As Co-investigator:
 

Sl. No.

Title of Project

Funding Agency

Amount

Sanctioned

Status

1.

 

 

2.

 

 

3.          

Design and Evaluation of Transdermal Drug Delivery of Selected Drug

Transdermal Delivery of Selected Drugs: Design, In-vitro and In-vivo Evaluation

Design, Development and Optimization of Self Nanoemulsifying and Solidified Self Nanoemulsifying Drug Delivery Systems of Anti-tubercular Drugs

AICTE (TAPTEC)

 

U G C -MRP

 

 

DBT

Rs. 10.00 lacs

 

 

Rs. 7.08 lacs

 

 

Rs. 14.494

lacs

Completed

(2005)

 

Completed

(2007)

 

 
Completed
(2012)
 

 



  Patent
 
  1. Kalyan K. Sethi, Sourav M. Verma. 4,5,6,7-tetrabromo-1,3-dioxoisoindolin-2-yl benzenesulfonamide derivatives. Ref. no.: E-2/2087/2013-KOL, Application no.: 567/KOL/2013. Indian Patent office, at Kolkata, India. (Complete Specification)

  Fellow
 

1. Fellow of Institution of Chemist (FIC)

2. Fellow of Indian Chemical Society (FICS)